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Hemidesmosomes are cellular attachment structures of great importance to the epidermis. In this issue of
Immunity, Zhang et al. (2015) have discovered that in addition to having structural functions, invertebrate
and human hemidesmosomes are actively monitored by the cell as a novel mechanism for detecting patho-
genic infection.Recognition of microbial infection leads to
transcriptionof host defensegenes inwhat
is termed the host response. Nematodes
are peculiar in the sense that they are
able to detect infection by bacteria and
fungi without the usual pattern-recognition
receptors (toll-like receptors, NOD-like re-
ceptors,and the like). Formanyyearssince
the initial application of C. elegans to the
study of the innate immune system, the
mechanisms by which worms can detect
infection were a mystery. In this issue of
Immunity, Zhang et al. (2015) shed light
on such pathogen-recognition mecha-
nisms and for the first time implicate hemi-
desmosomes as cellular structures whose
integrity is monitored by a transcription
factor for the detection of epidermal infec-
tion. What they found has direct relevance
to human health.
Zhang et al. (2015) tested the hypothe-
sis that structural components of the
cell—that is, the actin and tubulin cyto-
skeletons, intermediate filaments, and
hemidesmosomes—are subject to sur-
veillance. They disrupted each compo-
nent individually, either by RNAi-mediated
gene knockdown or by chemical inhibi-
tion, and subsequently examined the
expression of cnc-2 and nlp-29, two
representative epidermal host defense
genes. Previous studies by the Ewbank
laboratory showed that cnc-2 and nlp-29
are members of antimicrobial gene fam-
ilies that are induced in the epidermis
upon fungal infection, epidermal wound-
ing, or osmotic stress (Pujol et al., 2012).
Perhaps surprisingly, damage of the
collagenous exoskeleton, body-wall mus-
cles, or the actin and tubulin cytoskele-
tons had no major effect on cnc-2 or
nlp-29 expression. In contrast, inactiva-206 Immunity 42, February 17, 2015 ª2015 Etion of hemidesmosome subunit MUP-4,
or of its extracellular partner BLI-1,
caused an increase in the expression of
both antimicrobial genes. Despite also
affecting the structure of the epidermis,
disruption of other hemidesmosome
components did not result in the same in-
duction of cnc-2 or nlp-29 unless they
also disrupted MUP-4 subcellular locali-
zation, suggesting that MUP-4 function
specifically controls the host response to
epidermal damage.
Hemidesmosomes are trans-cellular
protein complexes that hold the epidermal
cell together with the apical collagen
exoskeleton and the basal muscle fibers.
To begin to unravel the mechanisms by
which MUP-4 could control epidermal
defense gene expression, the authors fol-
lowed a sequence of elegant genetic and
cell-biological experiments. First, they
examined the role of previously known
epidermal signal-transduction cascades,
namely the p38-MAPK signaling pathway
centered on p38 homolog PMK-1, the
neuronal transforming growth factor b
(TGF-b) pathway triggered by TGF-b ho-
molog DBL-1, WNK-type protein kinase
WNK-1, and GATA transcription factor
ELT-3. None of these pathways were
required for MUP-4-driven cnc-2 and
nlp-29 induction.
However, a recently identified homolog
of human transcription factor STAT5B,
named STA-2 in worms, was required for
induction of the antimicrobial genes after
MUP-4 inactivation. Zhang et al. (2015)
discovered that STA-2 co-localizes with
apical MUP-4 in naive animals, only to
disappear from MUP-4 structures upon
insult. Co-immunoprecipitation experi-
ments were consistent with the interpre-lsevier Inc.tation that MUP-4 and STA-2 form a com-
plex, suggesting a molecular mechanism
by which hemidesmosome integrity might
be monitored. Upon hemidesmosome
disruption, STA-2 might detach from the
apical membrane, shuttle to the nucleus,
and drive the induction of antimicrobial
genes such as cnc-2 and nlp-29 (Figure 1).
In innovative experiments with glass
shards, the authors found evidence to
support this hypothesis: the degree of
nlp-29 activation correlated with the de-
gree of hemidesmosome disruption and
with the severity of epidermal damage.
The requirement of p38-MAPK signaling
only existed at low to moderate signal in-
tensity: after high-intensity damage, the
p38 pathway was dispensable for nlp-29
induction, suggesting that STA-2 activa-
tion alone can be sufficient for the host
response if the damage is severe enough.
Crucially, the final step was to test the
relevance of this mechanism of cellular
surveillance in human cells. Keratinocytes
are themajor cell typeof humanskin. Inpri-
mary keratinocytes, Zhang et al. (2015)
targeted several cellular structural compo-
nents and found that direct or indirect
hemidesmosome disruptionwas sufficient
for the induction of antimicrobial b-defen-
sin and pro-inflammatory cytokines inter-
leukin-6 (IL-6) and IL-8. Furthermore,
inhibition of all seven human STAT tran-
scription factors revealed a requirement
of STAT3 and STAT5B for this effect, in
parallel with the worm epidermal pathway.
Thus, not only are hemidesmosomes sub-
ject to surveillance for innate immunity
throughout phylogeny, but the specific
hemidesmosome-STAT pathway is also
evolutionarily conserved. This is strong
evidence that hemidesmosome integrity
Figure 1. Proposed Model of STA-2-Mediated Signaling from the Hemidesmosome
Left: general logic of effector-triggered host responses. A pathogen produces factors that disrupt an essential cellular process, such as a structural component.
Such disruption produces an alarm signal (possibly the disruption itself), which is transduced to transcriptional regulators. Thus activated, the transcriptional
regulators increase expression of host defense genes.
Right: Zhang et al. (2015) propose a model where disruption of hemidesmosomes, specifically subunit MUP-4, leads to release of putative transcription factor
STA-2 from the apical membrane of the epidermal cell. Thus released, cytosolic STA-2 can enter the nucleus, where it drives the expression of cnc-2 and nlp-29,
two fungus-induced genes that encode antimicrobial proteins.
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Previewsmight be an important indicator of system
health in humanskin andmight be involved
in host defense and chronic inflammatory
conditions such as urticaria or eczema.
Furthermore, hereditary skin diseases
(such as epidermolysis bullosa), which
derive from defective cell adhesion in the
skin, have an important and crippling
inflammatory component (Turcan and
Jonkman, 2014). The work by Zhang
et al. (2015) raises thepossibility that hemi-
desmosome-STAT5B signaling might be
involved—and might be a therapeutic
target.
Tissue destruction and cell injury are
a common theme in infections. Further-
more, several pathogens have evolved
to subtly disrupt or manipulate essential
host cellular processes to their advan-
tage. Examples include the manipulation
of the host actin cytoskeleton for attach-
ment and engulfment or the interruption
of important innate immune and inflam-
mation signaling pathways by so-called
pathogen effectors. Pathogen effectors
are essentially cellular saboteur proteins,and many are injected into the host cell
cytoplasm to exert their functions of
disarming host defense or modifying the
cellular milieu to suit the pathogen’s
needs. Effector-triggered host responses,
also known as effector-triggered immu-
nity (ETI), are defense responses elicited
in the host by the detection of the results
of effector function within the host cell
(Stuart et al., 2013)—in other words,
when the effector’s cover is blown.
First identified in plants, ETI has
recently been found to operate in animals,
from invertebrates to vertebrates. The first
study to explicitly test the existence of ETI
in animals was conducted in Drosophila,
and shortly thereafter, several studies
demonstrated its existence in nematodes
as well (Boyer et al., 2011). The processes
known to be under surveillance in worms
include translation and mitochondrial
integrity (Dunbar et al., 2012; Liu et al.,
2014; McEwan et al., 2012). Thus, the dis-
covery by Zhang et al. (2015) of the hemi-
desmosome-STAT pathway in worms
and in humans might be a novel mecha-Immunity 42,nism of ETI-related surveillance and is of
great significance.
As all good work, the present study
raises many important questions. Aside
from its requirement for the hemidesmo-
some signal, the molecular mechanism
of STA-2 function is not known. By anal-
ogy to the better known example of
STAT5B, its human homolog, one might
expect STA-2 to possess DNA binding
and transcription factor activity. In order
to understand the mechanisms by which
STA-2 and STAT5B serve the host during
infection and injury, it is necessary to
define their target genes and downstream
pathways. Upstream, human STAT tran-
scription factors are controlled by re-
ceptor-associated kinases, such as JAK
(O’Shea et al., 2015). The role of JAK-
like kinases in the hemidesmosome-
STAT host defense pathway is unknown.
Thework by theEwbank andZhang lab-
oratories suggests that STA-2 participates
in responses to injury and infection. Are
these two scenarios molecularly equiva-
lent in the context of the epidermis, or areFebruary 17, 2015 ª2015 Elsevier Inc. 207
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Previewsadditional signals integrated to produce
responses that are more tailored to the
insult? How does the hemidesmosome
pathway integrate and crosstalkwith other
STAT-mediated pathways? To which hu-
man diseases is this new signal-transduc-
tion mechanism relevant? And perhaps
most pressingly, how can we harness this
mechanism to enhance human health?
We might not know the answer to these
key questions yet, but with the new knowl-
edge described in Zhang et al., we are on
our way to finding out.208 Immunity 42, February 17, 2015 ª2015 EREFERENCES
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Fusobacterium nucleatummight be the cause or consequence of disease in many tissues in and outside the
mouth. In this issue of Immunity, Gur et al. (2015) suggest a new mechanism by which this oral commensal
might help cancer cells escape host immunity.The gastrointestinal tract accommodates
the vast majority of the microbes that
inhabit the human body. Fusobacterium
nucleatum, an anaerobic Gram-oral com-
mensal, is associated with periodontitis,
adverse pregnancy outcomes (APO), car-
diovascular disease (CVD), rheumatoid
arthritis (RA), inflammatory bowel disease
(IBD), and colorectal carcinoma (CRC)
(Han, 2015). How F. nucleatum might
contribute to the pathogenesis of such
diverse clinical spectrum is unknown.
One might ask whether the presence of
the bacterium in the amniotic fluid and
fetal membranes, for example, is a cause
or a consequence of pre-term labor and
stillbirth—the pathogenesis of which are
also largely unknown. F. nucleatum from
the maternal oral cavity has been re-
ported to translocate to fetal tissues and
cause stillbirth (Han et al., 2010).
F. nucleatum might cause periodontitis
and fetal demise in mice, by interacting
with NKp46 (Chaushu et al., 2012) orTLR4 (Liu et al., 2007) and triggering
inflammation.
One is however left wondering how
bacteria naturally resident in the oral
cavity find their way into the placenta,
let alone the amniotic sac (Figure 1).
Bacteria might access fetal tissues by
ascending from the uro-genital tract as a
consequence of cervical changes.Moving
from themouth to the colon seems amore
straightforward translocation for bacteria,
although F. nucleatum is usually not found
in stools—which reflect the composition
of the luminal flora—and is often found in
mucosal specimens of both healthy and
inflamed intestinal biopsies. This would
attest to the invasive nature of virulent
F. nucleatum subspecies. Invasive iso-
lates of F. nucleatum are indeed more
often associated with pathological intesti-
nal biopsies, including those from patients
with IDB or CRC. Oral bacteria might enter
the blood circulation during transient bac-
teremia and translocate to different sitesthrough this alternative route, whichmight
contribute to turning them into pathogens.
Is the bacterium a causative agent or is its
presence a consequence of the condition
or is it simply a passenger?
In this issue of Immunity, Gur et al. (2015)
suggest potential mechanisms that might
explain how F. nucleatum allies with can-
cer cells (Gur et al., 2015). The teammakes
a credible case that F. nucleatum inter-
feres with host immunity by engaging its
bacterial protein Fap2 with the inhibitory
immunoreceptor TIGIT on natural killer
(NK) and T cells (Figure 1). Immune cells
do infiltrate tumors in most patients and
in some patients the tumor micro-environ-
ment is inflammatory and conducive to a
productive response against cancer cells.
Particularly in CRC, the extent of lympho-
cytic infiltrate is a favorable prognostic
marker. Getting in the tumor and actually
destroying cancer cells are two separate
tasks and the latter is frankly a big ask of
cytotoxic cells. Indeed, many cells and
